Advertisement
Advertisement

TPST

TPST logo

Tempest Therapeutics, Inc. Common Stock

1.99
USD
Sponsored
+0.02
+1.02%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

2.06

+0.07
+3.77%

Tempest Therapeutics, Inc. Common Stock Profile

About

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.

Info & Links

CEO

Matthew Angel

Headquarters

2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE, CA 94005, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.tempesttx.com

Auditor

Ernst & Young LLP

Share holders

60

Employees

4

Tempest Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

29.62M

Enterprise Value

21.91M

Enterprise Value/EBITDA(ttm)

-0.83

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.17

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-309.60%

Return on Invested Capital(ttm)

-293.62%

Return on Assets(ttm)

-115.81%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-26.31M

Net Income Available to Common(ttm)

-26.26M

Diluted EPS(ttm)

-6.64

Share Statistics

Beta (5Y Monthly)

-2.00

52-Week Change

-41.90%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

14.34M

Dividend Yield

0.00%

Float4

13.44M

% Held by Insiders

6.28%

% Held by Institutions

22.52%

Balance Sheet

Total Cash(mrq)

7.71M

Total Cash Per Share(mrq)

0.54

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.50%

Quick Ratio(mrq)

2.50%

Book Value Per Share(mrq)

1.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.46

Free Cash Flow(ytd)

-26.82M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement